Search Results
You are looking at 1 - 7 of 7 items for
- Author: T Yoshida x
- Refine by access: All content x
Search for other papers by K Tomita in
Google Scholar
PubMed
Search for other papers by T Yoshida in
Google Scholar
PubMed
Search for other papers by J Morita in
Google Scholar
PubMed
Search for other papers by S Atsumi in
Google Scholar
PubMed
Search for other papers by T Totsuka in
Google Scholar
PubMed
Abstract
The in vivo responsiveness of thyroid glands to TSH at various ages in novel 'growth-retarded' (grt/grt) mice derived from Snell's dwarf (DW/J) mice and in their normal counterparts were analysed by determining serum T4 concentrations before and after the administration of exogenous TSH. The serum T4 concentration in normal mice increased in response to TSH at 2, 4 and 12 weeks of age but not at 1 week of age. A transient augmentation of such thyroidal responsiveness to TSH was apparent in normal mice at 2 weeks of age, when the serum T4 level exhibits a peak and the pubertal growth of mice starts. In contrast to normal mice, at any age examined from 2 to 12 weeks after birth, exogenous TSH did not influence serum T4 concentrations in the grt/grt mice at all. On the other hand, serum TSH concentrations in young grt/grt mice were highly elevated compared with those in normal mice and they were normalized by a 2–3 week's treatment with T3. Morphological studies demonstrated degenerated thyroid glands in the grt/grt mice. These results suggest that the severe hypothyroidism and consequent growth retardation in growth-retarded mice are due to impairment of the thyroid glands of the mutant mice in producing and/or secreting thyroid hormones in response to TSH.
Journal of Endocrinology (1995) 144, 209–214
Search for other papers by T. MORI in
Google Scholar
PubMed
Search for other papers by Y. YOSHIDA in
Google Scholar
PubMed
Search for other papers by T. NISHIMURA in
Google Scholar
PubMed
Search for other papers by T. KONO in
Google Scholar
PubMed
Search for other papers by S. YAMADA in
Google Scholar
PubMed
Search for other papers by S. TATSUMI in
Google Scholar
PubMed
SUMMARY
A 27-year-old patient with a hilus cell tumour of the ovary giving rise to secondary amenorrhea and marked virilization was studied clinically and endocrinologically, and the tumour was examined by light and electron microscopy. Clinical, roentogenological and endocrinological studies showed that the ovarian tumour was the source of excessive androgen production. Urinary 17-oxosteroid excretion was always higher than 65 mg./day. The urinary production rates of testosterone, dehydroepiandrosterone and dehydroepiandrosterone sulphate were 1970 mg./day, 98·5 mg./day and 31·9 mg./day, respectively. Postoperatively, the androgenic manifestations gradually subsided, and the menstrual cycle returned to normal.
Search for other papers by M. Nonomura in
Google Scholar
PubMed
Search for other papers by K. Hoshino in
Google Scholar
PubMed
Search for other papers by T. Harigaya in
Google Scholar
PubMed
Search for other papers by H. Hashimoto in
Google Scholar
PubMed
Search for other papers by O. Yoshida in
Google Scholar
PubMed
ABSTRACT
Hyperprolactinaemia induced by pituitary isografts in male host mice was confirmed by radioimmunoassay, but plasma testosterone levels determined by radioimmunoassay in these mice showed no changes. Immunoenzyme electron microscopic observations revealed large spherical-shaped immunoreactive prolactin granules in pituitary grafts in male hosts, regardless of the sex of the donor mice, indicating the disappearance of sexual dimorphism in prolactin-producing cells in hyperprolactinaemic mice. In hyperprolactinaemic host mice the male accessory sex glands, particularly the seminal vesicle and the ventral prostate, exhibited considerable proliferation and significant increase in weight. These phenomena do not seem to be mediated by the increased action of testosterone. Such biological effects in host mice were much greater when the donor was female rather than male, and were more noticeable in C57BL mice than in C3H mice.
J. Endocr. (1985) 107, 71–76
Feed Functionality Research Laboratory, Meiji Feed Co., Kashima, Ibaraki 314-0103, Japan
Search for other papers by K Katoh in
Google Scholar
PubMed
Feed Functionality Research Laboratory, Meiji Feed Co., Kashima, Ibaraki 314-0103, Japan
Search for other papers by K Yoshioka in
Google Scholar
PubMed
Feed Functionality Research Laboratory, Meiji Feed Co., Kashima, Ibaraki 314-0103, Japan
Search for other papers by H Hayashi in
Google Scholar
PubMed
Feed Functionality Research Laboratory, Meiji Feed Co., Kashima, Ibaraki 314-0103, Japan
Search for other papers by T Mashiko in
Google Scholar
PubMed
Feed Functionality Research Laboratory, Meiji Feed Co., Kashima, Ibaraki 314-0103, Japan
Search for other papers by M Yoshida in
Google Scholar
PubMed
Feed Functionality Research Laboratory, Meiji Feed Co., Kashima, Ibaraki 314-0103, Japan
Search for other papers by Y Kobayashi in
Google Scholar
PubMed
Feed Functionality Research Laboratory, Meiji Feed Co., Kashima, Ibaraki 314-0103, Japan
Search for other papers by Y Obara in
Google Scholar
PubMed
Postprandial changes in plasma concentrations of GH, insulin, IGF-I, leptin and metabolites were compared between young Holstein bull calves fed with milk alone (control group) and with milk+5′-uridylic acid (UMP) (UMP group). UMP (2 g/day) was given with milk at 0830 h and 1530 h for 11 days from the 4th to the 14th day after birth. The perirenal fat weight was significantly lower in the UMP group than in the control group, but there was no significant difference in the weights of the liver, spleen and heart between the groups. Basal GH concentrations in the UMP group were slightly higher, but the postprandial increase in plasma insulin level and the area under the curve for insulin in the UMP group were significantly lower than those in the control group. There was no significant difference in IGF-I levels between the groups. In addition, the postprandial glucose concentrations were lower in the UMP group as reflected by the insulin level, and nonesterified fatty acid concentrations were not different. In the muscle (M. longissimus thoracis) sampled at 14 days of age, the triacylglycerol (TAG) content was significantly greater but glycogen content was significantly lower in the UMP group than in the control group. From these results, we have concluded that feeding 5′-UMP at 2 g/day for 11 days significantly alters TAG accumulation in the body and plasma concentrations of GH and insulin in young bull calves.
Search for other papers by T Yoshida in
Google Scholar
PubMed
Search for other papers by K Yamanaka in
Google Scholar
PubMed
Search for other papers by S Atsumi in
Google Scholar
PubMed
Search for other papers by H Tsumura in
Google Scholar
PubMed
Search for other papers by R Sasaki in
Google Scholar
PubMed
Search for other papers by K Tomita in
Google Scholar
PubMed
Search for other papers by E Ishikawa in
Google Scholar
PubMed
Search for other papers by H Ozawa in
Google Scholar
PubMed
Search for other papers by K Watanabe in
Google Scholar
PubMed
Search for other papers by T Totsuka in
Google Scholar
PubMed
Abstract
This paper describes a novel mutant mouse that has been spontaneously derived from the Snell's dwarf (DW/J) mouse. It was named the 'growth-retarded mouse' because of a characteristic growth pause followed by the delayed onset of pubertal growth. The onset of the increase in pituitary GH content that normally occurs concomitant with pubertal growth was also delayed in the growth-retarded mice. The serum concentration of thyroxine was very low in these mice from the neonatal period through adulthood, and a supplement of tri-iodothyronine was effective in shortening the growth pause and commencing the suppressed pubertal growth. Histological and immunohistochemical studies revealed that the anterior pituitary gland of the growth-retarded mouse contains clustered unusual chromophobic cells which are not reactive to various antisera against anterior pituitary hormones and the gland becomes enlarged with age. Breeding data indicated that these characteristics of the mice show an autosomal recessive inheritance and the gene responsible was designated as 'grm'. Partial linkage analysis utilizing microsatellite polymorphism demonstrated that the grm gene does not identify with the lit or hyt genes. Based on comparison of the hormonal status and growth pattern between growth-retarded, dwarf and normal mice, we have suggested the existence of a mutual interaction, possibly positive feedback regulation, between the pituitary and thyroid glands, that develops or matures the hormonal network which is responsible for rapid somatic growth and metabolic changes at puberty in mice.
Journal of Endocrinology (1994) 142, 435–446
Search for other papers by A. Nagasaka in
Google Scholar
PubMed
Search for other papers by S. Yoshida in
Google Scholar
PubMed
Search for other papers by A. Nakai in
Google Scholar
PubMed
Search for other papers by T. Ohyama in
Google Scholar
PubMed
Search for other papers by K. Iwase in
Google Scholar
PubMed
Search for other papers by S. Ohtani in
Google Scholar
PubMed
Search for other papers by H. Nakagawa in
Google Scholar
PubMed
Search for other papers by R. Masunaga in
Google Scholar
PubMed
Search for other papers by S. Kato in
Google Scholar
PubMed
Search for other papers by T. Kawabe in
Google Scholar
PubMed
Search for other papers by K. Kataoka in
Google Scholar
PubMed
ABSTRACT
Using hypophysectomized rats, it has been shown that DNA polymerase-β activity in the adrenal gland and testis is largely influenced by pituitary trophic hormones. Sucrose gradient centrifugation of thyroid extracts revealed three peaks of DNA polymerase-β activity sedimenting at 3·3S, 7·3S and 12S. Of these, hypophysectomy induced a decrease in the 3·3S DNA polymerase-β, whereas other molecular forms were affected only slightly. DNA polymerase-α and -γ activities were unaffected by hypophysectomy. These changes in DNA polymerase-β caused by hypophysectomy were reversed by daily i.p. injection of TSH. Furthermore, stimulation of the thyroid by excess TSH induced by the administration of 1-methyl-2-mercaptoimidazole resulted in an increase of all forms of thyroid DNA polymerase-β.
These results show that the level of DNA polymerase is relatively constant after hypophysectomy but that DNA polymerase-β in the rat thyroid gland is also modulated by TSH mainly through the change of activity of the polymerase-β which sediments at 3·3S.
J. Endocr. (1988) 119, 303–308
Search for other papers by A Mori-Abe in
Google Scholar
PubMed
Search for other papers by S Tsutsumi in
Google Scholar
PubMed
Search for other papers by K Takahashi in
Google Scholar
PubMed
Search for other papers by M Toya in
Google Scholar
PubMed
Search for other papers by M Yoshida in
Google Scholar
PubMed
Search for other papers by B Du in
Google Scholar
PubMed
Search for other papers by J Kawagoe in
Google Scholar
PubMed
Search for other papers by K Nakahara in
Google Scholar
PubMed
Search for other papers by T Takahashi in
Google Scholar
PubMed
Search for other papers by M Ohmichi in
Google Scholar
PubMed
Search for other papers by H Kurachi in
Google Scholar
PubMed
Proliferation of vascular smooth muscle cells (VSMC) plays a major role as an initiating event of atherosclerosis. Although estrogen directly inhibits the proliferation of VSMC, the mechanism has not been firmly established. In addition, the effect of raloxifene on VSMC remains unknown. 17Beta-estradiol (E(2)) and raloxifene significantly inhibited the growth of VSMC under growth-stimulated conditions. Since mitogen-activated protein (MAP) kinases have been implicated in VSMC proliferation, the role of MAP kinases in both the E(2)- and raloxifene-induced growth inhibition of VSMC was studied. Both E(2) and raloxifene caused rapid, transient phosphorylation and activation of p38 that was not affected by actinomycin D and was blocked by ICI 182,780. In contrast with p38 phosphorylation, extracellular signal-regulated protein kinase (ERK) phosphorylation was significantly inhibited and c-Jun N-terminal kinase (JNK) phosphorylation was not changed by E(2). Because VSMC expressed both estrogen receptor (ER) alpha and ERbeta, it is not known which of them mediates the E(2)-induced phosphorylation of p38. Although E(2) did not affect the p38 phosphorylation in A10 smooth muscle cells, which express ERbeta but not ERalpha, transfection of ERalpha expression vector into A10 cells rendered them susceptible to induction of p38 phosphorylation by E(2). We then examined whether E(2) and raloxifene induce apoptosis through a p38 cascade. Both E(2) and raloxifene induced apoptosis under growth-stimulated conditions. The p38 inhibitor SB 203580 completely blocked the E(2)-induced apoptosis. Our findings suggest that both E(2)- and raloxifene-induced inhibition of VSMC growth is due to induction of apoptosis through a p38 cascade whose activation is mediated by ERalpha via a nongenomic mechanism.
